JP2008532516A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008532516A5 JP2008532516A5 JP2008500763A JP2008500763A JP2008532516A5 JP 2008532516 A5 JP2008532516 A5 JP 2008532516A5 JP 2008500763 A JP2008500763 A JP 2008500763A JP 2008500763 A JP2008500763 A JP 2008500763A JP 2008532516 A5 JP2008532516 A5 JP 2008532516A5
- Authority
- JP
- Japan
- Prior art keywords
- increased
- reduced
- cells
- average
- mean
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66117305P | 2005-03-11 | 2005-03-11 | |
| US74052205P | 2005-11-29 | 2005-11-29 | |
| PCT/US2006/007353 WO2006098887A2 (en) | 2005-03-11 | 2006-02-27 | Gene disruptions, compositions and methods relating thereto |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009049942A Division JP2009168820A (ja) | 2005-03-11 | 2009-03-03 | 遺伝子破壊、組成物、およびそれに関連する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008532516A JP2008532516A (ja) | 2008-08-21 |
| JP2008532516A5 true JP2008532516A5 (https=) | 2009-04-23 |
Family
ID=36992194
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008500763A Pending JP2008532516A (ja) | 2005-03-11 | 2006-02-27 | 遺伝子破壊、組成物、およびそれに関連する方法 |
| JP2009049942A Pending JP2009168820A (ja) | 2005-03-11 | 2009-03-03 | 遺伝子破壊、組成物、およびそれに関連する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009049942A Pending JP2009168820A (ja) | 2005-03-11 | 2009-03-03 | 遺伝子破壊、組成物、およびそれに関連する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110097330A1 (https=) |
| EP (1) | EP1863340A2 (https=) |
| JP (2) | JP2008532516A (https=) |
| AU (1) | AU2006223579A1 (https=) |
| CA (1) | CA2601677A1 (https=) |
| WO (1) | WO2006098887A2 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
| US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
| PT1781682E (pt) | 2004-06-24 | 2013-05-14 | Mayo Foundation | B7-h5, um polipéptido coestimulante |
| US8989833B2 (en) | 2004-07-13 | 2015-03-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
| US8231872B2 (en) * | 2005-04-25 | 2012-07-31 | The Trustees Of Dartmouth College | Regulatory T cell mediator proteins and uses thereof |
| WO2007067991A2 (en) | 2005-12-08 | 2007-06-14 | Medarex, Inc. | Human monoclonal antibodies to o8e |
| CA2663523A1 (en) * | 2006-11-14 | 2008-10-23 | Genentech, Inc. | Novel gene disruptions, compositions and methods relating thereto |
| WO2009105709A1 (en) | 2008-02-21 | 2009-08-27 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
| JP5602850B2 (ja) | 2009-07-14 | 2014-10-08 | ザ スクリプス リサーチ インスティテュート | 間葉幹細胞分化 |
| WO2011027132A1 (en) | 2009-09-03 | 2011-03-10 | Cancer Research Technology Limited | Clec14a inhibitors |
| AU2012267492A1 (en) * | 2011-06-10 | 2014-01-09 | President And Fellows Of Harvard College | Modulation of pancreatic beta cell proliferation |
| AR087329A1 (es) | 2011-06-17 | 2014-03-19 | Regeneron Pharma | Anticuerpos humanos contra proteina 3 de tipo angiopoietina humana |
| WO2013033513A1 (en) | 2011-08-31 | 2013-03-07 | University Of Georgia Research Foundation, Inc. | Apoptosis-targeting nanoparticles |
| JP6356614B2 (ja) | 2012-02-17 | 2018-07-11 | ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド | 薬剤のミトコンドリア輸送のためのナノ粒子 |
| MA38369B1 (fr) | 2013-03-08 | 2018-10-31 | Novartis Ag | Peptides et compositions pour le traitement d'une lesion de l'articulation |
| UY35368A (es) | 2013-03-08 | 2014-10-31 | Irm Llc | Péptidos y composiciones para el tratamiento de daño articular |
| EP2968569A4 (en) | 2013-03-15 | 2016-11-02 | Argenta Mfg Ltd | COUGAR FORMULATION |
| US10398663B2 (en) | 2014-03-14 | 2019-09-03 | University Of Georgia Research Foundation, Inc. | Mitochondrial delivery of 3-bromopyruvate |
| SG11201806176PA (en) * | 2016-02-04 | 2018-08-30 | Regeneron Pharma | Non-human animals having an engineered angptl8 gene |
| MA43734A (fr) | 2016-03-03 | 2018-11-28 | Regeneron Pharma | Procédés de traitement de patients atteints d'hyperlipidémie par administration d'un inhibiteur de pcsk9 en combinaison avec un inhibiteur d'angptl3 |
| US10961305B2 (en) | 2016-12-21 | 2021-03-30 | Mereo Biopharma 3 Limited | Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta |
| BR112019022447A2 (pt) | 2017-04-27 | 2020-06-09 | Retinopathy Answer Limited | sistema e método para análise de imagem funduscópica automatizada |
| US11306144B2 (en) | 2017-08-25 | 2022-04-19 | Five Prime Therapeutics, Inc. | B7-H4 antibodies and methods of use thereof |
| BR112020016986A2 (pt) | 2018-02-21 | 2021-03-02 | Five Prime Therapeutics, Inc. | formulações de anticorpo contra b7-h4 |
| KR20200144094A (ko) | 2018-03-02 | 2020-12-28 | 파이브 프라임 테라퓨틱스, 인크. | B7-h4 항체 및 이의 사용 방법 |
| WO2019173283A1 (en) | 2018-03-05 | 2019-09-12 | Marquette University | Method and apparatus for non-invasive hemoglobin level prediction |
| TW202027794A (zh) | 2018-10-03 | 2020-08-01 | 瑞士商諾華公司 | 血管生成素樣３多肽之持續遞送 |
| EP3965740A1 (en) * | 2019-05-10 | 2022-03-16 | KetoSwiss AG | Ketone bodies enclosed in microbeads |
| US12559551B2 (en) | 2019-05-24 | 2026-02-24 | Regeneron Pharmaceuticals, Inc. | Stabilized formulations containing anti-ANGPTL3 antibodies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166132A1 (en) * | 1998-08-26 | 2003-09-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| JP2003518361A (ja) * | 1998-09-01 | 2003-06-10 | ジェネンテック・インコーポレーテッド | 更なるｐｒｏポリペプチドとその配列 |
| KR100553300B1 (ko) * | 1999-03-08 | 2006-02-20 | 제넨테크, 인크. | 혈관신생 및 심혈관형성의 촉진 또는 억제 방법 |
| KR100543857B1 (ko) * | 1999-09-01 | 2006-01-23 | 제넨테크, 인크. | 혈관신생 및 심혈관형성의 촉진 또는 억제 |
| AU6802801A (en) * | 2000-03-01 | 2001-09-24 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2002040662A2 (en) * | 2000-11-15 | 2002-05-23 | Deltagen, Inc. | Transgenic mice containing targeted gene disruptions |
| AU2002239539A1 (en) * | 2000-12-06 | 2002-06-18 | Deltagen, Inc. | Transgenic mice containing targeted gene disruptions |
-
2006
- 2006-02-27 AU AU2006223579A patent/AU2006223579A1/en not_active Abandoned
- 2006-02-27 JP JP2008500763A patent/JP2008532516A/ja active Pending
- 2006-02-27 CA CA002601677A patent/CA2601677A1/en not_active Abandoned
- 2006-02-27 US US11/722,967 patent/US20110097330A1/en not_active Abandoned
- 2006-02-27 WO PCT/US2006/007353 patent/WO2006098887A2/en not_active Ceased
- 2006-02-27 EP EP06736637A patent/EP1863340A2/en not_active Withdrawn
-
2009
- 2009-03-03 JP JP2009049942A patent/JP2009168820A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008532516A5 (https=) | ||
| Lundberg et al. | Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPα-interaction | |
| Isho et al. | Fantastic IgA plasma cells and where to find them | |
| Kruger et al. | Stereochemical control yields mucin mimetic polymers | |
| ES2655591T3 (es) | Métodos para la regulación de células madre | |
| KR101508397B1 (ko) | 염증성 장 질환의 검출 방법 | |
| KR20240116566A (ko) | 노화 세포 치료를 위한 단백질 치료제 | |
| JP2009168820A (ja) | 遺伝子破壊、組成物、およびそれに関連する方法 | |
| DE60128701T2 (de) | Claudin polypeptide | |
| WO2012061537A2 (en) | Methods for treating hair loss disorders | |
| CA2298540A1 (en) | Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof | |
| JP2003524387A (ja) | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 | |
| JP6890835B2 (ja) | 腫瘍細胞を非腫瘍細胞に変換するための医薬的連合体及びその使用 | |
| Braitch et al. | The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS) | |
| DE69931284T9 (de) | Menschliches Neurotrimin-Homolog | |
| Singh et al. | Functional roles of osteoactivin in normal and disease processes | |
| JP2005511012A (ja) | ヒトｃＤＮＡおよびタンパク質およびその使用 | |
| Yang et al. | Quadruped gait and regulation of apoptotic factors in Tibiofemoral joints following intra-articular rhPRG4 injection in Prg4 null mice | |
| JP2021138720A (ja) | 腫瘍細胞を非腫瘍細胞に変換するための医薬的連合体及びその使用 | |
| ES2262819T3 (es) | Ligando natural para el receptor gpr86 acoplado a proteinas g huerfano y metodos de uso. | |
| WO2005099774A2 (en) | Diagnosis and treatment of myeloid and lymphoid cell cancers | |
| Yang et al. | Structural insight for roles of DR5 death domain mutations on oligomerization of DR5 death domain–FADD complex in the death-inducing signaling complex formation: a computational study | |
| US10485849B2 (en) | Syndecan peptides and polypeptides as inhibitors of vascular endothelial growth factor receptor-2 (VEGFR2) and very late antigen-4 (VLA-4) | |
| WO2023034993A1 (en) | Compositions and methods for diagnosing, detecting and treating eosinophil-related diseases | |
| DE60120507T2 (de) | Menschliches leucinreiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1 |